Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
The scientific community's reliance on active-controlled trials is steadily increasing, as widespread agreement emerges concerning the role of these trials as viable alternatives to placebo trials. These trials present substantial challenges with regard to design and interpretation as their complexi...
שמור ב:
| הוצא לאור ב: | Curr Control Trials Cardiovasc Med |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514891/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15312236/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1468-6708-5-8 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|